The Role of CNI-1493 in the Function of Primary Microglia with respect to Amyloid-beta

Manuscript Number: 

11-0179R2

Author(s): 
Yousef Al-Abed, Jan-Philipp Bach, Michael Bacher, Monika Balzer-Geldsetzer, Richard Dodel, Andreas Kautz, David Mengel, Tina Wahle

Disclosures

Yousef Al-Abed

  • Equity:
    i hold stock options in Cytokinepharmasciences
    Patents/Royalties
    I am an invenor on a patent related to CNI-1493 and AD

Jan-Philipp Bach

  • Lecture Fees:
    TEVA Pharma GmbH

Michael Bacher

  • Nothing to Disclose

Monika Balzer-Geldsetzer

  • Nothing to Disclose

Richard Dodel

  • Consulting Fees:
    Rentschler, Lilly, GE Healthcare, Baxter, Octapharma
    Lecture Fees:
    Bohringer Ingelheim, GSK, Lundbeck, Merz, Novartis, Octapharma, Pfizer, Solvay, Eisai, Orion Pharma, UCB, Affiris, Abbott, GE Healthcare, Desitin
    Grants
    • Agency: 
      Lundbeck
      Dates: 
      2010-2011

Andreas Kautz

  • Nothing to Disclose

David Mengel

  • Nothing to Disclose

Tina Wahle

  • Nothing to Disclose